检索

期
标题
作者
编号 4 (2023)
Effectiveness of early start of menopausal hormone therapy in the menopausal transition: comparative analysis of therapy
Gasparyan S., Chotchaeva A., Karpov S.
PDF
(Rus)
编号 2 (2023)
Comparative analysis of estrogen metabolites when using different forms of estrogen-containing medications in a cryo-protocol for preparation with gonadotropin-releasing hormone agonists
Kvashnina E., Tutakov M., Tomina E., Shilova N.
PDF
(Rus)
编号 3 (2024)
Satisfaction of young women with Estradiol Valerate/Dienogest in real clinical practice in Russia: results of prospective multicenter observational study Q-SWAN
Prilepskaya V., Andreeva E.
PDF
(Rus)
编号 11 (2023)
Results of bioequivalence studies on the oral contraceptives levonorgestrel+ethinylestradiol, desogestrel+ethinylestradiol and nomegestrol+estradiol in healthy volunteers
Dumanovskaya M.
PDF
(Rus)
编号 6 (2023)
Impact of systemic menopausal hormone therapy on symptoms of urinary incontinence in postmenopausal women
Makovskaya D., Apolikhina I., Gorbunova E., Yureneva S.
PDF
(Rus)
编号 7 (2019)
Ton-contraceptive benefits of combined oral contraceptives: opportunities for the correction of vaginal microbiocenosis
Kutsenko I., Kravtsova E., Rubinina E.
PDF
(Rus)
编号 10 (2022)
Rationale for the choice of menopausal hormone therapy if treatment switching is needed in the context of a personalized approach
Tapilskaya N., Bespalova O., Kogan I.
PDF
(Rus)
编号 10 (2018)
Current possibilities of combined hormonal contraception
Aganezova N., Aganezov S.
PDF
(Rus)
编号 2 (2014)
Endometrial receptivity in an in-vitro fertilization program
Mityurina E., Perminova S., Demura T., Gallyamova E.
PDF
(Rus)
编号 11 (2021)
Experience in the use of low-dosed levonorgestrel-containing intrauterine system LCS16 and combined oral contraceptive containing 30 mcg ethinyl estradiol and 3 mg drospirenone in young women
Suturina L., Dikke G.
PDF
(Rus)
编号 3 (2017)
New technologies in gynecology: A fixed extended hormonal contraceptive regimen
Aganezova N., Aganezov S.
PDF
(Rus)
编号 3 (2013)
BIOCHEMICAL MARKERS OF THREATENED MISCARRIAGE
KOVALENKO A., KALININA N., ALEKSEENKOVA M., PANINA O., SAVELYEVA G.
PDF
(Rus)
编号 11 (2021)
Effect of hormone replacement therapy with estradiol in frozen embryo transfer on estrogen metabolism in women with various polymorphisms of catechol-O-methyltransferase gene
Kvashnina E., Tutakov M., Vakhlova O., Tomina E., Shilova N.
PDF
(Rus)
编号 5 (2017)
ESR1 and VEGFA gene polymorphisms as a predictor for the course of ovarian hyperstimulation syndrome in an in vitro fertilization program
Strelchenko D., Perminova S., Donnikov A.
PDF
(Rus)
编号 2 (2011)
COMPARATIVE ANALYSIS OF FOLLITROPIN ALPHA OVULATION STIMULATION IN THE USE OF GONADOTROPIN-RELEASING HORMONE AGONISTS OR HIGH-DOSE ETHINYL ESTRADIOL IN PATIENTS WITH PREMATURE OVARIAN FAILURE
MARCHENKO L., ZHAKHUR N., BUTAREVA L., KUZMICHEV L., MIKAELYAN V.
PDF
(Rus)
编号 9 (2021)
Features of endometrial tissue metabolism of androgens: a modern view
Gavisova A., Shevtsova M., Tskhovrebova L.
PDF
(Rus)
编号 4 (2016)
Molecular genetic predictors for the development of ovarian hyperstimulation syndrome in an IVF program
Strelchenko D., Perminova S., Donnikov A., Kadochnikova V., Abramov D., Korneeva I., Saroyan T., Abubakirov I.
PDF
(Rus)
编号 6 (2021)
The problem of sarcopenia in postmenopausal women. Prevention opportunities
Sandakova E., Zhukovskaya I., Timofeeva E.
PDF
(Rus)
编号 11 (2015)
EFFICIENCY OF USING COMBINED ORAL CONTRACEPTIVES, ESTRADIOL VALERATE, AND GONADOTROPIN-RELEASING HORMONE ANTAGONIST FOR THE PROGRAMMING OF IN VITRO FERTILIZATION CYCLES
MARTYNOVA M., MISHIEVA N., LEVKOV L., MARTAZANOVA B., LAPINA V., BOGATYREVA K., ABUBAKIROV A.
PDF
(Rus)
编号 10 (2015)
Predictors for the development of ovarian hyperstimulation syndrome in an IVF program
Strelchenko D., Perminova S., Donnikov A.
PDF
(Rus)
编号 4 (2019)
Issues of acceptability and safety when choosing combined oral contraceptives
Dovletkhanova E., Mgeryan A., Abakarova P.
PDF
(Rus)
编号 6 (2015)
THE HORMONAL PROFILE IN WOMEN AT HIGH RISK FOR OVARIAN HYPERSTIMULATION SYNDROME AFTER REPLACEMENT OF AN OVULATION TRIGGER
MARTAZANOVA B., MISHIEVA N., VEDIKHINA I., AKSENENKO A., EAPEN S., IBRAGIMOVA M., IVANETS T., ABUBAKIROV A.
PDF
(Rus)
编号 1 (2023)
Results of bioequivalence studies on dienogest, progesterone, and levonorgestrel+estradiol in healthy volunteers after single dose intake during fasting
Apolikhina I., Tarnaeva L., Kondratyeva N.
PDF
(Rus)
编号 5 (2019)
The role of NOD1 and NOD2 receptors in recognizing pathogens in the female reproductive tract
Lebedeva O.
PDF
(Rus)
编号 5 (2015)
PERSONALIZED APPROACH TO USING MIFEPRISTONE IN PATIENTS WITH UTERINE MYOMA
Kareva E., Bekhbudova L., Gorenkova O., Samoilova T.
PDF
(Rus)
1 - 25 的 25 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##